Lin Maosong, Duan Bensong, Hu Jiangfeng, Yu Hong, Sheng Haihui, Gao Hengjun, Huang Junxing
Department of Gastroenterology, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Department of Gastroenterology, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, P.R. China.
Oncol Lett. 2017 Jul;14(1):1061-1067. doi: 10.3892/ol.2017.6266. Epub 2017 May 26.
Epithelial-mesenchymal transition (EMT) is an early and key process in the metastatic cascade during the progression of colorectal cancer (CRC). The aim of the present study was to identify deregulated EMT-related microRNAs (miRNAs/miRs) of CRC and assess the effect of differentially expressed miRNAs on the prognosis of patients with CRC. Genome-wide expression profiling of miRNAs was assessed in 3 EMT-negative and 3 EMT-positive CRC tissues. Differentially expressed miRNA was further validated in 90 pairs of CRC and corresponding paracarcinoma tissues using the reverse transcription-quantitative polymerase chain reaction (RT-qPCR). A total of 6 miRNAs (miR-10a-5p miR-204-3p, miR-1224-3p, miR-193a-3p, miR-365a-3p and miR-3678-3p) were identified to be differentially expressed between different EMT statuses of CRC tissues. Following validation using RT-qPCR, 3 miRNAs (miR-10a-5p, miR-365a-3p and miR-193a-3p) were selected for subsequent studies. The expression levels of miR-10a-5p, miR-193a-3p and miR-365a-3p were markedly increased compared with levels in corresponding paracarcinoma tissues. Survival analyses revealed that down-regulation of miR-193a-3p was associated with worse prognosis of patients with CRC, particularly in female and older patients. The results of the present study indicate that miR-193a-3p may be an EMT-related biomarker and serve as a novel prognostic factor for CRC.
上皮-间质转化(EMT)是结直肠癌(CRC)进展过程中转移级联反应的早期关键过程。本研究的目的是鉴定CRC中失调的EMT相关微小RNA(miRNA/miRs),并评估差异表达的miRNA对CRC患者预后的影响。在3个EMT阴性和3个EMT阳性的CRC组织中评估了miRNA的全基因组表达谱。使用逆转录定量聚合酶链反应(RT-qPCR)在90对CRC及相应癌旁组织中进一步验证差异表达的miRNA。共鉴定出6种miRNA(miR-10a-5p、miR-204-3p、miR-1224-3p、miR-193a-3p、miR-365a-3p和miR-3678-3p)在CRC组织的不同EMT状态之间差异表达。经RT-qPCR验证后,选择3种miRNA(miR-10a-5p、miR-365a-3p和miR-193a-3p)进行后续研究。与相应癌旁组织相比,miR-10a-5p、miR-193a-3p和miR-365a-3p的表达水平显著升高。生存分析显示,miR-193a-3p的下调与CRC患者的预后较差相关,尤其是在女性和老年患者中。本研究结果表明,miR-193a-3p可能是一种EMT相关生物标志物,可作为CRC的一种新的预后因素。